Breaking the time capsule: Life Sciences in 2010 and today
CRA’s Life Sciences Practice team recently analyzed past predictions of industry trends and compared them to what has occurred in the past decade, identified...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
“Digital Health” continues to evolve quickly, with technological innovations providing new opportunities for patients, providers, and payers. Despite the clear opportunity to improve health through digitally-enabled interventions, it remains challenging to achieve commercial success for digital products. Key challenges include securing favorable market access and reimbursement, incorporating digital tools into provider workflows, and optimizing the patient experience.
Informed by decades of experience developing go-to-market strategies for health technologies (pharma, biotech, MedTech, DTx, etc.), our team brings deep expertise in value demonstration, access and reimbursement, pricing, demand generation, and business model development to overcome the uptake and payment hurdles facing emerging digital technologies.
CRA’s Life Sciences Practice team recently analyzed past predictions of industry trends and compared them to what has occurred in the past decade, identified...
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health...